Sinotherapeutics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	4,616	4,517	4,978	7,593	-	-
Market Cap Growth	1.88%	-9.25%	-34.45%	-	-	-
Enterprise Value	3,850	3,769	4,194	6,771	-	-
Last Close Price	10.28	10.00	10.83	16.44	-	-
PE Ratio	48.53	35.37	81.50	81.71	-	-
PS Ratio	9.61	8.83	16.60	30.67	-	-
PB Ratio	3.53	3.55	4.11	6.45	-	-
P/TBV Ratio	3.63	3.66	4.28	6.74	-	-
P/FCF Ratio	135.03	127.97	-	-	-	-
P/OCF Ratio	38.52	34.69	384.14	103.76	-	-
EV/Sales Ratio	8.01	7.37	13.99	27.35	-	-
EV/EBITDA Ratio	37.92	27.36	62.24	80.84	-	-
EV/EBIT Ratio	44.38	31.55	94.67	116.33	-	-
EV/FCF Ratio	112.64	106.79	-	-	-	-
Debt / Equity Ratio	0	0	0	0.00	0.01	-
Debt / EBITDA Ratio	0.00	0.00	0.00	0.02	0.04	-
Debt / FCF Ratio	0.00	0	-	-	0.03	-
Net Debt / Equity Ratio	-0.58	-0.58	-0.62	-0.68	-0.72	-0.77
Net Debt / EBITDA Ratio	-7.54	-5.32	-11.11	-9.62	-4.18	-3.21
Net Debt / FCF Ratio	-22.39	-20.78	28.81	7.81	-3.91	-2.53
Asset Turnover	0.33	0.36	0.22	0.23	0.39	0.51
Inventory Turnover	2.69	2.63	2.34	1.96	1.71	2.29
Quick Ratio	10.84	8.19	9.13	9.76	6.21	3.37
Current Ratio	12.21	9.46	10.49	10.59	6.91	3.83
Return on Equity (ROE)	7.75%	10.29%	5.12%	9.87%	21.29%	24.97%
Return on Assets (ROA)	3.76%	5.31%	2.06%	3.31%	7.41%	12.26%
Return on Invested Capital (ROIC)	14.20%	21.46%	9.84%	19.49%	52.09%	71.98%
Return on Capital Employed (ROCE)	6.30%	8.80%	3.50%	4.70%	12.30%	20.60%
Earnings Yield	2.14%	2.83%	1.23%	1.22%	-	-
FCF Yield	0.74%	0.78%	-0.52%	-1.36%	-	-
Dividend Yield	0.48%	0.62%	0.38%	0.38%	-	-
Payout Ratio	28.24%	21.83%	46.02%	-	-	-
Buyback Yield / Dilution	0.93%	2.92%	-11.22%	-3.32%	-0.21%	-
Total Shareholder Return	1.41%	3.54%	-10.84%	-2.94%	-0.21%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.